MKI67 and neoplasm: Immunostaining analysis of lung HCC44 tumor sections showed that combination treatment resulted in lower number of Ki67+ proliferative cells and more TUNEL+ apoptotic cells than MRTX849 or HuSC1-39 alone (Fig. 5C).